Fig. 4From: Development of highly efficient niosomal systems for co-delivery of drugs and genes to treat breast cancer in vitro and in vivo a IC50 analysis of various formulations of fCur and NCur in cancer cells. b Measured live cancerous cells were treated by the fCur, NCur, and NmiR. c Measured live cancerous cells treated by niosomal NPs at \(37\) and \(42 ^\circ \mathrm{C}\) for 24 h. d Cell viability of the niosomal NPs in cancerous cells at \(37\) and \(42 ^\circ \mathrm{C}\) for 48. h, e Cell viability of the niosomal NPs in cancerous at \(37\) and \(42 ^\circ \mathrm{C}\) for 72 hBack to article page